TAI · —

SCI Pharmtech, Inc. (4119.TW) Stock

$53.50 -3.95% TAI: 4119.TW —

—

Valuation

MetricValue
Price$53.50
Market Cap$6.66B
P/E Ratio111.40
P/B Ratio1.25
P/S Ratio5.28
EPS (TTM)$0.50
52-Week High$60.70
52-Week Low$39.60
Dividend Yield1.35%

Financials & Margins

MetricValue
ROE1.12%
ROA0.93%
ROCE—
Gross Margin24.21%
Operating Margin3.42%
Net Margin4.77%
Debt/Equity0.20
Current Ratio1.25

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA21.54
FCF Yield—
Quick Ratio0.33
Interest Coverage—
Return 1Y-6.51%
Return 3Y-38.67%
Return 5Y-16.93%

About SCI Pharmtech, Inc.

—

SCI Pharmtech, Inc. (4119.TW) stock trades at $53.50 with a market capitalization of $6.66B. The stock is valued at a price-to-earnings (P/E) ratio of 111.40, price-to-book of 1.25, price-to-sales of 5.28. Over the past 52 weeks the stock has ranged between $39.60 and $60.70, and currently trades 11.9% below its 52-week high. It pays a dividend yielding 1.35%.

On profitability, SCI Pharmtech, Inc. generates a return on equity (ROE) of 1.12%, an operating margin of 3.42%, a net profit margin of 4.77%.

Official website: www.sci-pharmtech.com.tw

SCI Pharmtech, Inc. (4119.TW) — frequently asked questions

What is SCI Pharmtech, Inc. (4119.TW) stock price today?

SCI Pharmtech, Inc. (4119.TW) is currently trading at $53.50, down 3.95% today.

What is 4119.TW P/E ratio?

SCI Pharmtech, Inc.'s P/E ratio is 111.40. This is above the typical market average of roughly 18-22x. A high P/E often reflects higher expected earnings growth, a temporary dip in earnings, or both.

What is 4119.TW return on equity (ROE)?

SCI Pharmtech, Inc.'s return on equity (ROE) is 1.12%. ROE measures net income relative to shareholders' equity. This is below the typical market range of roughly 12-15%.

What is SCI Pharmtech, Inc.'s market cap?

SCI Pharmtech, Inc. has a market capitalization of $6.66B.

Does 4119.TW pay a dividend?

Yes. SCI Pharmtech, Inc. currently yields 1.35%. Yield moves with the share price, so it changes daily even when the payment does not.

How much debt does 4119.TW carry?

SCI Pharmtech, Inc. has a debt-to-equity ratio of 0.20. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is 4119.TW's profit margin?

SCI Pharmtech, Inc. reports a net profit margin of 4.77% — the share of revenue left after every cost, including tax and interest.

What sector is 4119.TW in?

SCI Pharmtech, Inc. is classified under —, in the — industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is 4119.TW listed on?

SCI Pharmtech, Inc. trades on TAI under the ticker 4119.TW.

What is 4119.TW's 52-week range?

Over the last year SCI Pharmtech, Inc. has traded between $39.60 and $60.70.

Related — Stocks

USDE StablecoinX Inc. $1.00 -0.01% APMD Apnimed, Inc. $18.99 +2.48% GLAS Glass House Brands Inc. Subordinate Voting Shares $2.14 -6.14% GIXI Gix Internet Ltd. $4.23 +4.44%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens 4119.TW currently matches

On the figures above, SCI Pharmtech, Inc. passes the filters for 6 of our ready-made screens, among them Dividend Stocks, Low Debt Stocks, High PE Stocks. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Dividend StocksLow Debt StocksHigh PE StocksStocks Under $100Mid Cap StocksDebt to Equity Below 1 Stocks

Related stock screens

High ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.